Trending

#ERA25

Latest posts tagged with #ERA25 on Bluesky

Latest Top
Trending

Posts tagged #ERA25

Thank you! I had real FOMO for #ERA25 so maybe!

1 0 0 0
Post image

En el Congreso europeo #ERA25 de European Renal Association, Eva Segura y la estudiante Helena Guillem de #Fisioterapia CEU UCH han presentado resultados con Juan Carlos Julián, director general de ALCER, Federación Española de Lucha Contra las Enfermedades del Riñón
medios.uchceu.es/actualidad-c...

0 0 0 0
Preview
Los resultados de GoodRENal, en Viena y Montreal La catedrática de Fisioterapia de la CEU UCH, Eva Segura, y la estudiante de Grado Helena Guillem han presentado en el congreso de la European Renal Association resultados de su actividad investigador...

De Viena a Montreal!
La catedrática de #Fisioterapia en CEU UCH Eva Segura, y la estudiante de Grado Helena Guillem han presentado resultados del proyecto europeo GoodRENal sobre #hemodiálisis y #ejercicio en el #ERA25 Congress y en la McGill University de Canadá
medios.uchceu.es/actualidad-c...

1 0 1 0
Post image

Thank you for joining! Was in the room when you presented the room at #ERA25 😊 #nephjc

7 1 0 0

Sarah Melville, Clinical Research Manager, Atlantic Canada; no COI... been looking forward to the #nephjc chat of this study since #ERA25 a few months ago, ;)

1 0 1 0

coool!, thanks!, this was one of my top 3 favourite trials that was presented at #ERA25 a few months ago... looking forward to the discussion, 🤓😃🙏

1 0 0 0
Preview
ARO-C3 Shows Early Promise for Reducing Complement Activation in IgA Nephropathy - Renal and Urology News ARO-C3 is an investigational RNA interference therapeutic designed to reduce liver production of complement component 3 as a potential therapy for various complement-mediated diseases.

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria.
www.renalandurologynews.com/reports/iga-... #ERA25

0 0 0 0

Reflecting on just the past 4-5 years, it's remarkable how much nephrology has evolved. What once took a decade to unfold now happens in the space of a single conference #ERA25

Hope that we will keep up the same pace

10 2 0 0
Post image

Cristina Popa, 🇷🇴 nephrologist

No COIs for tonight's #nephjc

Confidence reminds me of Vienna #ERA25

More pics from Schönbrunn Palace and the art museum

3 0 0 0
Post image

DON'T MISS 🎯 our latest issue, featuring the landscape of #xenotransplantation, coverage of #ERA25, Ajay Singh on sex differences in #eGFR, research news and interviews, and more. ➡️ www.docwirenews.com/journal/july... #nephrology #nephsky #kidney

0 0 0 0
Post image

🌍 #EuropeanResearchArea turns 25 in 2025 - a milestone for Europe’s shared #R&I vision! 🚀
#CASRI joins the effort, empowering EPAs to lead on sustainability and co-design #SRIA.
🔗 CASRI: www.casri.eu
🔗 ERA: european-research-area.ec.europa.eu
#ERA25 #Research #Innovation

6 3 0 1
Preview
Migraine Drug Linked With Lower Risk of ESKD - Renal and Urology News An observational study examined ESKD risk among patients with migraine taking vs not taking topiramate.

Topiramate, a drug for migraine prophylaxis, may have beneficial effects on the kidneys.
www.renalandurologynews.com/reports/end-... #ERA25

0 0 0 0
Preview
Sustained Complete Renal Response Lowers Mortality, Kidney Damage in Lupus Nephritis - Renal and Urology News Investigators identified factors associated with sustained complete renal response in lupus nephritis.

Duration of complete renal response (CRR) is more important than CRR achievement in itself for lupus nephritis prognosis.
www.renalandurologynews.com/reports/lupu... #ERA25

1 0 0 0
Login • Instagram Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.

Actually, we got to interview him for #era25- so it was rather a 3-person discussion 😎 #nephjc

www.instagram.com/reel/DKpFLs8...

1 1 0 0

#NephJC #ERA25

0 0 0 0
Post image

⏩ Next #NephJC on July 8, 2025 #Medsky

A late-breaker from #ERA25

www.nejm.org/doi/abs...

10 3 0 3
Preview
European Renal Association on Instagram: "NUDGE-CKD trial part 2/2 with dr Kristoffer Skaarup. Remember if you couldn’t make it to the sessions in real time you still have time to watch it on demand at ERA25 official site. #era25 #beyondnephrology #ckd #clinicaltrials" 21 likes, 0 comments - erakidney on June 8, 2025: "NUDGE-CKD trial part 2/2 with dr Kristoffer Skaarup. Remember if you couldn’t make it to the sessions in real time you still have time to watch it on demand at ERA25 official site. #era25 #beyondnephrology #ckd #clinicaltrials".

Now, a short break #NephJC

Here is what the main author said about NUDGE-CKD, after presenting the results #ERA25

www.instagram.com/re...

3 3 0 0
Post image

Cristina Popa, @nephroseeker.medsky.social 🇷🇴 nephrologist hosting. With an existentialist vision, tonight I’m here to gently push the conversation forward - one nudge at a time! #NephJC

No COI. Just in the room when the main author, Kristoffer Skaarup, presented the results during #ERA25

4 2 1 0
Preview
Tacrolimus Shows Efficacy for Treatment-Resistant Uremic Pruritus - Renal and Urology News Tacrolimus has previously shown antipruritic action in atopic dermatitis, so researchers decided to investigate it for uremic pruritus.

A trial supports the use of the calcineurin-inhibitor tacrolimus as a targeted treatment for uremic pruritus and introduces IL-13 inhibition as a viable mechanism to address cytokine-mediated itch.
www.renalandurologynews.com/reports/hemo... #ERA25

1 0 0 0
Preview
Persistent, Isolated Low C3 May Predict Lupus Nephritis Progression to ESKD - Renal and Urology News Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis.

Clinicians managing lupus nephritis should consider persistent isolated C3 as a possible indicator of long-term renal risk.
www.renalandurologynews.com/reports/lupu... #ERA25

1 0 0 0
Preview
Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes - Renal and Urology News A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.

Early genetic screening can help identify monogenic lupus nephritis and anticipate trajectory of disease.
www.renalandurologynews.com/reports/mono... #ERA25

1 0 0 0
Preview
Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes - Renal and Urology News A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.

Early genetic screening can help identify monogenic lupus nephritis and anticipate trajectory of disease.
www.renalandurologynews.com/reports/mono... #ERA25

1 0 0 0
Preview
Renal Hyperfiltration Trajectory Tied With Risk of ESKD, Cardiovascular Events, and Death - Renal and Urology News Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

Whether renal hyperfiltration persists or disappears, patients who experience it appear to be at increased risks of kidney failure, cardiovascular events, and all-cause mortality.
www.renalandurologynews.com/reports/end-... #ERA25

0 0 0 0
Video

All caught up on our #ERA25 episode of #KidneyCompass?

Use the link below for more on our episode with Chee Kay Cheung, MBChB, PhD!

www.hcplive.com/view/kidney-...

0 0 0 0
Preview
Spironolactone Does Not Lower CV Mortality, HF Hospitalization Risk in Patients on Dialysis - Renal and Urology News Although spironolactone is very effective in patients that do not require dialysis, investigators tested whether spironolactone is effective in patients on dialysis in a phase 3 trial.

Spironolactone did not lower cardiovascular risks in patients undergoing maintenance dialysis in the phase 3 ACHIEVE trial.
www.renalandurologynews.com/reports/spir... #ERA25

0 0 0 0
Preview
Inhibiting Factor XI Does Not Decrease Arteriovenous Graft Thrombosis Rate in Hemodialysis - Renal and Urology News Investigators evaluated the efficacy and safety of different doses of MK-2060, a monoclonal antibody against Factor XI, to prevent vascular access clotting in patients receiving hemodialysis via an ar...

A phase 2 trial of patients receiving hemodialysis via an arteriovenous graft found no benefit from a factor XI inhibitor.
www.renalandurologynews.com/reports/fact... #ERA25

0 0 0 0
Dr. Raj Mehrotra speaking at the podium.

Dr. Raj Mehrotra speaking at the podium.

Dr. @rajmehrotra.bsky.social presented "Public Policy and Home Dialysis Utilization" at the European Renal Association's #ERA25 62nd Congress in Vienna, Austria!! The event focused on "Breaking Boundaries in Kidney Care." A fantastic event for learning & sharing #kidneycare @uwmedicine.bsky.social

3 1 0 0
62nd ERA Congress - Profs. L. Pyne, F. Fakhouri, M. Walsh, H. Mann, N. Staplin, V. Stel & J. Barratt
62nd ERA Congress - Profs. L. Pyne, F. Fakhouri, M. Walsh, H. Mann, N. Staplin, V. Stel & J. Barratt YouTube video by MARKUS at HOMe

🤩 Great summary of Late Breaking Clinical trials and relevand studies presented during #ERA25

✨Fab panelists lineup @kateisabelle24.bsky.social @rosertorra.bsky.social @lonniepyne.bsky.social @lastwalsh.bsky.social

👏 @markusathome.bsky.social @gunnarheine.bsky.social

youtu.be/HbUEh8oLB2M?...

12 8 1 0
Preview
Kidney Compass: CONFIDENCE Trial at ERA 2025, with Rajiv Agarwal, MD, MS Brendon Neuen, MBBS, PhD, is joined by Rajiv Agarwal, MD, MS to explore the concept of simultaneous initiation of SGLT2i and nsMRA in CKD and T2D.

The CONFIDENCE trial confirmed the benefit and safety of combination SGLT2i and nsMRA in patients with CKD and #Type2DIabetes. Learn more about the landmark trial: www.hcplive.com/view...


#KidneyCompass #ERA25

0 0 0 0
Preview
Combo Therapy That Slashes UACR Could Be a Game Changer for CKD | Docwire News Rajiv Agarwal, MBBS, discussed a study showing that a finerenone and empagliflozin combination has superior efficacy at reducing UACR in chronic kidney disease and type 2 diabetes.

✔️ Check out our interview with Rajiv Agarwal, who presented at #ERA25 on the efficacy of pairing #finerenone and #empagliflozin to lower UACR. #nephsky #nephrology #kidneydisease #ckd #diabetes www.docwirenews.com/post/combo-t...

1 1 0 0